| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT00740714 Details | 2013-01-31 Interventional | 3 | 600 | Coenzyme Q10 Tocopherols Tocotrienols Ubiquinone Vitamin E Vitamins alpha-Tocophero… Parkinson Disea… | The investigational drug is unlikely to demonstrate efficacy over placebo for this indication.
However, no safety issues were discovered. The planned interim analysis for futility based on the first 300 subjects has reached the pre-specified termination criterion. | |||
| NCT01302899 2009-012196-10 Details | 2013-01-30 Interventional | 2 | 8 | Aliskiren Hydrochlorothia… Ramipril Albuminuria Kidney Diseases Non-diabetic Ne… | In consequence of termination of ALTITUDE. A number of studies were continued in consultation
with the Altitude Data Monitoring Committee. - | |||
| NCT01450410 Details | 2013-01-29 Interventional | 4 | 12 | Niacin Niacinamide Nicotinic Acids Dyslipidemias | Study terminated (halted prematurely) as recomended by the drug supplier and medical agencies - | |||
| NCT00563459 Details | 2013-01-29 Interventional | 3 | 89 | Levetiracetam Topiramate Epilepsy Seizures | Carisbamate partial onset seizures studies lacked consistent efficacy data so trials in this
indication were terminated. - | |||
| NCT01266811 Details | 2013-01-28 Interventional | 3 | 0 | BB 1101 Bortezomib Dexamethasone Dexamethasone a… Siltuximab Multiple Myelom… Neoplasms, Plas… | Study canceled based on results of different study with similar hypothesis, investigational
agent, & patient - | |||
| NCT00070122 Details | 2013-01-25 Interventional | 3 | 2200 | Antibodies Antibodies, Mon… Antineoplastic … Bevacizumab Capecitabine Fluorouracil Immunoglobulins Leucovorin Levoleucovorin Oxaliplatin Adenocarcinoma Colonic Neoplas… Rectal Neoplasm… Recurrence Adenocarcinoma … Adenocarcinoma … Recurrent Colon… Recurrent Recta… Stage III Colon… Stage III Recta… Stage IV Colon … Stage IV Rectal… | Administratively complete. - | |||
| NCT00060112 Details | 2013-01-25 Interventional | 1 | 15 | Gemcitabine Oblimersen Burkitt Lymphom… Hodgkin Disease Leukemia Leukemia, Lymph… Leukemia, T-Cel… Leukemia-Lympho… Lymphoma Lymphoma, B-Cel… Lymphoma, B-Cel… Lymphoma, Folli… Lymphoma, Large… Lymphoma, Large… Lymphoma, Mantl… Lymphoma, Non-H… Lymphoma, T-Cel… Lymphoma, T-Cel… Plasmablastic L… Precursor Cell … Recurrence Extranodal Marg… Nodal Marginal … Recurrent Adult… Recurrent Adult… Recurrent Adult… Recurrent Adult… Recurrent Adult… Recurrent Adult… Recurrent Adult… Recurrent Adult… Recurrent Cutan… Recurrent Grade… Recurrent Grade… Recurrent Grade… Recurrent Mantl… Recurrent Margi… Recurrent Small… Splenic Margina… Stage IV Adult … Stage IV Adult … Stage IV Adult … Stage IV Adult … Stage IV Adult … Stage IV Adult … Stage IV Adult … Stage IV Adult … Stage IV Cutane… Stage IV Grade … Stage IV Grade … Stage IV Grade … Stage IV Mantle… Stage IV Margin… Stage IV Small … Unspecified Adu… | Administratively complete. - | |||
| NCT00033449 Details | 2013-01-25 Interventional | 1 | 30 | Gefitinib Carcinoma Carcinoma, Squa… Laryngeal Disea… Laryngeal Neopl… Oropharyngeal N… Squamous Cell C… Stage III Squam… Stage III Squam… Stage III Squam… Stage III Squam… Stage IV Squamo… Stage IV Squamo… Stage IV Squamo… Stage IV Squamo… | Administratively complete. - | |||
| NCT00015912 Details | 2013-01-25 Interventional | 2 | 35 | Interferon alph… Interferon-alph… Interferons Thalidomide Lymphoma Lymphoma, Folli… Recurrence Recurrent Grade… Recurrent Grade… | Administratively complete. - | |||
| NCT00227474 Details | 2013-01-24 Interventional | 2 | 0 | Vaccines Breast Neoplasm… Breast Cancer | SWOG has decided to not pursue this trial - | |||
| NCT00096148 Details | 2013-01-24 Interventional | 2 | 120 | Antibodies Antibodies, Mon… Antineoplastic … Bevacizumab Cytarabine Idarubicin Immunoglobulins Hypereosinophil… Leukemia Leukemia, Basop… Leukemia, Eosin… Leukemia, Eryth… Leukemia, Megak… Leukemia, Monoc… Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Adult Acute Bas… Adult Acute Eos… Adult Acute Meg… Adult Acute Min… Adult Acute Mon… Adult Acute Mon… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Acute Mye… Adult Erythrole… Adult Pure Eryt… Childhood Acute… Childhood Acute… Childhood Acute… Childhood Acute… Childhood Acute… Childhood Acute… Childhood Acute… Childhood Acute… Childhood Acute… Secondary Acute… Untreated Adult… Untreated Child… | Administratively complete. - | |||
| NCT00086970 Details | 2013-01-24 Interventional | 1 | 32 | Ifosfamide O(6)-benzylguan… Neoplasms Unspecified Adu… | Administratively complete. - | |||
| NCT00086840 Details | 2013-01-24 Interventional | 2 | 60 | MTOR Inhibitors Sirolimus Temsirolimus Hodgkin Disease Leukemia Leukemia, Lymph… Leukemia, Lymph… Lymphoma Lymphoma, Large… Recurrence Recurrent Adult… Recurrent Adult… Refractory Chro… | Administratively complete. - | |||
| NCT00075491 Details | 2013-01-24 Interventional | 2 | 42 | Fenretinide Glioblastoma Gliosarcoma Recurrence Adult Giant Cel… Adult Glioblast… Adult Gliosarco… Recurrent Adult… | Administratively complete. - | |||
| NCT00070265 Details | 2013-01-24 Interventional | 2 | 80 | Capecitabine Oxaliplatin Colonic Neoplas… Neoplasm Metast… Rectal Neoplasm… Recurrence Liver Metastase… Recurrent Colon… Recurrent Recta… Stage IV Colon … Stage IV Rectal… | Administratively complete. - | |||
| NCT00049088 Details | 2013-01-24 Interventional | 1 | 24 | Antibodies Antibodies, Mon… Antineoplastic … Bevacizumab Docetaxel Immunoglobulins Neoplasms Unspecified Adu… | Administratively complete. - | |||
| NCT00030693 Details | 2013-01-24 Interventional | 1 | 42 | Metronidazole Vaccines Unspecified Adu… | Administratively complete. - | |||
| NCT00006773 Details | 2013-01-24 Interventional | 1 | 42 | Bortezomib Astrocytoma Glioblastoma Gliosarcoma Oligodendroglio… Recurrence Adult Anaplasti… Adult Anaplasti… Adult Giant Cel… Adult Glioblast… Adult Gliosarco… Recurrent Adult… | Administratively complete. - | |||
| NCT00006003 Details | 2013-01-24 Interventional | 2 | 35 | Semaxinib Melanoma Recurrent Melan… Stage IV Melano… | Administratively complete. - | |||
| NCT00005856 Details | 2013-01-24 Interventional | 1/2 | 59 | Oxaliplatin Glioblastoma Gliosarcoma Adult Giant Cel… Adult Glioblast… Adult Gliosarco… | Administratively complete. - |